Angiogenic proteins and adipocytokines as markers for prediction of preeclampsia

Hisashi Masuyama, Yuji Hiramatsu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Preeclampsia is characterized by the onset of high blood pressure and proteinuria in pregnancy, leading to substantial maternal and neonatal morbidity and mortality. It involves abnormal remodeling of the placental bed vasculature, placental ischemia and endothelial cell dysfunction. Defective placental development might reflect alterations in the levels of various biological markers. Affected patients show remarkable imbalances of angiogenic factors, including PlGF, soluble FMS-like tyrosine kinase 1, soluble endoglin and angiopoietin-2; these factors could therefore be potential markers for predicting preeclampsia with or without uterine artery Doppler ultrasonography. However, use of these markers to predict preeclampsia has yet to achieve the positive and negative likelihood ratios necessary if they are to be used in clinical practice. Large-scale studies using known markers are likely to identify suitable candidates that will enable greatly improved perinatal care, including prevention and better outcomes for patients with preeclampsia.

Original languageEnglish
Pages (from-to)717-725
Number of pages9
JournalExpert Review of Obstetrics and Gynecology
Volume5
Issue number6
DOIs
Publication statusPublished - Nov 2010

Fingerprint

Angiogenic Proteins
Adipokines
Pre-Eclampsia
Angiopoietin-2
Perinatal Care
Placentation
Doppler Ultrasonography
Uterine Artery
Angiogenesis Inducing Agents
Infant Mortality
Proteinuria
Protein-Tyrosine Kinases
Ischemia
Endothelial Cells
Biomarkers
Mothers
Hypertension
Morbidity
Pregnancy

Keywords

  • adipocytokine
  • angiogenic factor
  • placenta
  • prediction
  • preeclampsia

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine
  • Maternity and Midwifery
  • Pediatrics, Perinatology, and Child Health

Cite this

Angiogenic proteins and adipocytokines as markers for prediction of preeclampsia. / Masuyama, Hisashi; Hiramatsu, Yuji.

In: Expert Review of Obstetrics and Gynecology, Vol. 5, No. 6, 11.2010, p. 717-725.

Research output: Contribution to journalArticle

@article{a31dd06569cf48c09d51473df356b4f8,
title = "Angiogenic proteins and adipocytokines as markers for prediction of preeclampsia",
abstract = "Preeclampsia is characterized by the onset of high blood pressure and proteinuria in pregnancy, leading to substantial maternal and neonatal morbidity and mortality. It involves abnormal remodeling of the placental bed vasculature, placental ischemia and endothelial cell dysfunction. Defective placental development might reflect alterations in the levels of various biological markers. Affected patients show remarkable imbalances of angiogenic factors, including PlGF, soluble FMS-like tyrosine kinase 1, soluble endoglin and angiopoietin-2; these factors could therefore be potential markers for predicting preeclampsia with or without uterine artery Doppler ultrasonography. However, use of these markers to predict preeclampsia has yet to achieve the positive and negative likelihood ratios necessary if they are to be used in clinical practice. Large-scale studies using known markers are likely to identify suitable candidates that will enable greatly improved perinatal care, including prevention and better outcomes for patients with preeclampsia.",
keywords = "adipocytokine, angiogenic factor, placenta, prediction, preeclampsia",
author = "Hisashi Masuyama and Yuji Hiramatsu",
year = "2010",
month = "11",
doi = "10.1586/eog.10.53",
language = "English",
volume = "5",
pages = "717--725",
journal = "Expert Review of Obstetrics and Gynecology",
issn = "1747-4108",
publisher = "Expert Reviews Ltd.",
number = "6",

}

TY - JOUR

T1 - Angiogenic proteins and adipocytokines as markers for prediction of preeclampsia

AU - Masuyama, Hisashi

AU - Hiramatsu, Yuji

PY - 2010/11

Y1 - 2010/11

N2 - Preeclampsia is characterized by the onset of high blood pressure and proteinuria in pregnancy, leading to substantial maternal and neonatal morbidity and mortality. It involves abnormal remodeling of the placental bed vasculature, placental ischemia and endothelial cell dysfunction. Defective placental development might reflect alterations in the levels of various biological markers. Affected patients show remarkable imbalances of angiogenic factors, including PlGF, soluble FMS-like tyrosine kinase 1, soluble endoglin and angiopoietin-2; these factors could therefore be potential markers for predicting preeclampsia with or without uterine artery Doppler ultrasonography. However, use of these markers to predict preeclampsia has yet to achieve the positive and negative likelihood ratios necessary if they are to be used in clinical practice. Large-scale studies using known markers are likely to identify suitable candidates that will enable greatly improved perinatal care, including prevention and better outcomes for patients with preeclampsia.

AB - Preeclampsia is characterized by the onset of high blood pressure and proteinuria in pregnancy, leading to substantial maternal and neonatal morbidity and mortality. It involves abnormal remodeling of the placental bed vasculature, placental ischemia and endothelial cell dysfunction. Defective placental development might reflect alterations in the levels of various biological markers. Affected patients show remarkable imbalances of angiogenic factors, including PlGF, soluble FMS-like tyrosine kinase 1, soluble endoglin and angiopoietin-2; these factors could therefore be potential markers for predicting preeclampsia with or without uterine artery Doppler ultrasonography. However, use of these markers to predict preeclampsia has yet to achieve the positive and negative likelihood ratios necessary if they are to be used in clinical practice. Large-scale studies using known markers are likely to identify suitable candidates that will enable greatly improved perinatal care, including prevention and better outcomes for patients with preeclampsia.

KW - adipocytokine

KW - angiogenic factor

KW - placenta

KW - prediction

KW - preeclampsia

UR - http://www.scopus.com/inward/record.url?scp=78249290551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78249290551&partnerID=8YFLogxK

U2 - 10.1586/eog.10.53

DO - 10.1586/eog.10.53

M3 - Article

VL - 5

SP - 717

EP - 725

JO - Expert Review of Obstetrics and Gynecology

JF - Expert Review of Obstetrics and Gynecology

SN - 1747-4108

IS - 6

ER -